The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Wave Life Sciences Ltd (NASDAQ: WVE) closed at $8.16 in the last session, down -1.92% from day before closing price of $8.32. In other words, the price has decreased by -$1.92 from its previous closing price. On the day, 1.93 million shares were traded. WVE stock price reached its highest trading level at $8.5668 during the session, while it also had its lowest trading level at $7.75.
Ratios:
We take a closer look at WVE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.56 and its Current Ratio is at 2.56. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on July 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $24.
On July 16, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 13 ’25 when Verdine Gregory L. sold 30,000 shares for $6.95 per share. The transaction valued at 208,500 led to the insider holds 282,517 shares of the business.
GREGORY VERDINE bought 30,000 shares of WVE for $216,000 on Jun 13 ’25. On Mar 20 ’25, another insider, HENRY CHRISTIAN O, who serves as the Director of the company, sold 10,500 shares for $9.77 each. As a result, the insider received 102,574 and left with 16,115 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1269394176 and an Enterprise Value of 1119690112. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.51 while its Price-to-Book (P/B) ratio in mrq is 9.12. Its current Enterprise Value per Revenue stands at 11.918 whereas that against EBITDA is -8.003.
Stock Price History:
The Beta on a monthly basis for WVE is -0.94, which has changed by 0.32467532 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $5.04. The 50-Day Moving Average of the stock is 14.87%, while the 200-Day Moving Average is calculated to be -19.39%.
Shares Statistics:
According to the various share statistics, WVE traded on average about 1.44M shares per day over the past 3-months and 1592770 shares per day over the past 10 days. A total of 155.67M shares are outstanding, with a floating share count of 124.26M. Insiders hold about 20.12% of the company’s shares, while institutions hold 80.77% stake in the company. Shares short for WVE as of 1752537600 were 16405588 with a Short Ratio of 11.43, compared to 1749772800 on 14881762. Therefore, it implies a Short% of Shares Outstanding of 16405588 and a Short% of Float of 14.39.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
